期刊文献+

IgA肾病与微生物免疫的研究进展 被引量:3

Advances in research on IgA nephropathy and microbe-related immune mechanisms
下载PDF
导出
摘要 IgA肾病(IgAN)是最常见的慢性肾小球肾炎之一,但明确的病因和发病机制仍不清楚。该疾病与多种潜在机制有关,其中黏膜免疫反应是重要的致病因素之一。而微生物产生的IgA蛋白酶和细胞因子都会在免疫作用中引起相应的组织学改变。目前,微生物的多样性分析与IgAN患者的临床疗效和预后有紧密的联系。随着致病机制相关研究的开展,许多IgAN的临床治疗数据也逐渐被发现。因此,探讨IgAN与微生物相关的免疫机制对IgAN的有效治疗具有重要意义。 IgA nephropathy(IgAN)is one of the most common types of chronic glomerulonephritis,but the definite etiology and pathogenesis of IgAN are still unclear.IgAN is related to a variety of potential mechanisms,among which mucosal immune response is one of the important pathogenic factors.However,IgA protease and cytokines produced by microorganisms can cause corresponding histological changes via immune pathways.At present,the microbial diversity is considered to be closely related to the efficacy of clinical treatment and prognosis of IgAN.With the increasing researches on related pathogenic mechanisms,the clinical data of IgAN treatment have been on the rise as well.Therefore,exploring the microbe-related immune mechanisms in IgAN is of great significance for the effective treatment of IgAN.
作者 朱安超 杨鑫鑫 候云晶 孟宏学 An-chao Zhu;Xin-xin Yang;Yun-jing Hou;Hong-xue Meng(Department of Pathology,Harbin Medical University Cancer Hospital,Harbin,Heilongjiang 150081,China)
出处 《中国现代医学杂志》 CAS 北大核心 2021年第2期33-37,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81600539) 哈尔滨医科大学附属肿瘤医院杰出青年项目(No:JCQN2018-05)。
关键词 IGA肾病 免疫机制 微生物多样性 扁桃体切除术 IgA nephropathy immune mechanism microbial diversity tonsillectomy
  • 相关文献

参考文献5

二级参考文献40

  • 1刘刚,马序竹,邹万忠,王梅,王海燕.肾活检患者肾脏病构成十年对比分析[J].临床内科杂志,2004,21(12):834-838. 被引量:182
  • 2Alexander Swidsinski,Vera Loening-Baucke,Herbert Lochs,Laura P.Hale.Spatial organization of bacterial flora in normal and inflamed intestine: A fluorescence in situ hybridization study in mice[J].World Journal of Gastroenterology,2005,11(8):1131-1140. 被引量:27
  • 3Roberts IS. Pathology of lgA nephropathy[J]. Nat Rev Nephrol 2014,10:445 - 454.
  • 4Wyatt RJ. Julian BA. lgA nephropathy[J]. N Engl J Med, 2013 368:2402 - 2414.
  • 5Boyd AS. Leflunomide in dermatology [ J ]. J Am Acad Dermatol 2012,66:673 - 679.
  • 6Pozzi C, Andrulli S, Del Vecehio L, et al. Corticosteroid effective- ness in lgA nephropathy: long - term results of a randomized, con- trolled trial[ J ]. J Am Soc Nephrol, 2004,15 : 157 - 163.
  • 7Chapple IL, Genco R. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases [ J 1. J Periodontol, 2013, 84 (4 Suppl) : S106-Sl12. DOI: 10. 1902/jop. 2013. 1340011.
  • 8Engebretson S, Koeher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis [J]. J Periodontol, 2013, 84(4 Suppl) : S153-S169. DOI: 10. 1902/jop. 2013.1340017.
  • 9D'Aiuto F, Nibali L, Parkar M, et al. Oxidative stress, systemic inflammation, and severe periodontitis[ J]. J Dent Res, 2010, 89 ( 11 ) :1241-1246. DOI: 10. 1177/0022034510375830.
  • 10Graziani F, Cei S, La Ferla F, et al. Effects of non-surgical periodontal therapy on the glomerular filtration rate of the kidney : an exploratory trial[ J ]. J Clin Periodontol, 2010, 37 (7) : 638- 643. DOI: 10. llll/j. 1600-051X. 2010.01578. x.

共引文献316

同被引文献29

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部